Clinical trial
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With…
NCT00256841 · Clinical Oncology Research Associates, Other · Withdrawn
Key facts
| NCT number | NCT00256841 |
|---|---|
| Title | Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy |
| Official title | Dose Escalation of Xeloda or 5FU Continuous Infusion in Combination With Taxotere and Concurrent Once Weekly, Hypofractionated Chest Radiotherapy for Advanced Non Small Cell Lung Cancer: A Phase I/II Study |
| Lead sponsor | Clinical Oncology Research Associates, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug, Procedure |
| Interventions | Chemotherapy, Radiation Therapy |
| Enrollment | 0 |
| Start date | Sep 1, 2005 |
| Completion | Oct 1, 2007 |
| First posted | Nov 22, 2005 |
| Last update posted | Jan 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: